Related Experiment Video

Updated: May 3, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epidemiologic study

James Davis1, Benjamin Chavez, Deborah T Juarez

  • 1John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.

The Annals of Pharmacotherapy
|January 23, 2014
PubMed

Insights

Medication adjustments for diabetes are infrequent, but when made, they significantly lower glycated hemoglobin (HbA1c) levels. Despite rising HbA1c, many patients do not have their treatment adjusted, indicating potential clinical inertia.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Public Health

Background:

  • Type 2 diabetes management requires regular monitoring of glycated hemoglobin (HbA1c) levels.
  • Suboptimal glycemic control, indicated by elevated HbA1c, necessitates timely medication adjustments.
  • Understanding medication adjustment patterns is crucial for improving diabetes care outcomes.

Purpose of the Study:

  • To investigate the association between rising HbA1c levels and medication adjustments in diabetic patients.
  • To evaluate the impact of medication adjustments on subsequent HbA1c levels.

Main Methods:

  • Retrospective analysis of administrative data from 7654 type 2 diabetes patients in Hawaii.
  • Inclusion criteria: HbA1c > 7%, oral diabetic medications, and specific HbA1c measurement and follow-up periods.
  • Patients categorized by HbA1c change; medication adjustments and subsequent HbA1c levels were tracked.

Main Results:

  • Medication adjustments occurred in less than 25% of patients.
  • Patients with higher HbA1c increases were more likely to have medication adjustments.
  • Adjustments led to an average HbA1c reduction of approximately 0.40% after 120 days.

Conclusions:

  • Limited responsiveness to elevated HbA1c levels and low insulin initiation rates were observed.
  • Medication adjustments, though infrequent, resulted in clinically significant HbA1c improvements.
  • Clinical inertia and patient factors may contribute to delayed medication adjustments.
Abstract

Keywords:
HbA1cclinical inertiadiabetesmedication adjustment

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.3K

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30